Jarislowsky, Fraser Ltd’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.21M | Buy |
17,262
+2,580
| +18% | +$180K | 0.01% | 138 |
|
|
2025
Q1 | $1.08M | Sell |
14,682
-1,365
| -9% | -$100K | 0.01% | 140 |
|
|
2024
Q4 | $1.05M | Buy |
16,047
+3,655
| +29% | +$239K | 0.01% | 140 |
|
|
2024
Q3 | $965K | Sell |
12,392
-1,727
| -12% | -$135K | 0.01% | 140 |
|
|
2024
Q2 | $1.1M | Buy |
14,119
+36
| +0.3% | +$2.81K | 0.01% | 139 |
|
|
2024
Q1 | $954K | Buy |
14,083
+2,320
| +20% | +$157K | 0.01% | 148 |
|
|
2023
Q4 | $792K | Sell |
11,763
-74
| -0.6% | -$4.98K | ﹤0.01% | 165 |
|
|
2023
Q3 | $802K | Buy |
11,837
+3,025
| +34% | +$205K | 0.01% | 149 |
|
|
2023
Q2 | $631K | Buy |
+8,812
| New | +$631K | ﹤0.01% | 154 |
|